Rearch homepage new banner Nov 2013

AstraZeneca is a global biopharmaceutical company with research and development at its core

Our expertise research and development spans the entire life-cycle of a medicine. We have capabilities in both small molecules and biologics. This allows us to search for solutions to unmet medical needs using both modalities, individually or in combination


Petrov Institute: Working together to lead personalised cancer research in Russia

IMED collaboration case studies

This video features the N.N. Petrov Institute for Oncology, one of Russia’s leading cancer research institutions. Together, we are working to identify innovative new approaches to treating cancer.

Download case study (PDF 242kb)


AstraZeneca’s Innovative Medicines & Early Development (IMED) Biotech Unit collaborates with hundreds of academic institutions and biotechs across the globe, in an effort to bring novel medicines to patients faster. Our scientists collaborate across geographic borders, accessing and adding to the best ideas, wherever they may be. Our collaboration partners tell us they enjoy working with AstraZeneca. But don’t take our word for it. Hear it from them.


Our leaders iconOur leaders

All Directors are collectively responsible for the success of AstraZeneca. Discover general information,  images and biographies of our Board of Directors.

Read more


Pipeline iconOur pipeline

AstraZeneca's pipeline is one of the most exciting in the industry. Download the latest version of our development pipeline.

Read more


Path to meds iconPath to new medicines

The discovery, development and commercialisation of a medicine is a complex process. Information on our path to new medicines and an interactive overview are available.

Read more


Neuro iconAZ Neuroscience

Visit our dedicated neuroscience site for more information on our research and partnering in the area.

 

Visit site


Open innovation iconOpen innovation

Visit our Open Innovation site to see how we collaborate to push the boundaries of science and deliver life-changing medicines

Visit site


LabTalk is AstraZeneca’s science-focused blog where you can hear from scientists, researchers and academics discussing novel ideas, research and innovation.

Searching_for_the_rare_THM 31 October 2014

Searching for the EGFR mutation prospective gefitinib study

Nobel_Prize_II_THM 20 October 2014

Stimulating the next generation: the Nobel Prize Inspiration Initiative

A_neuroscience_vision_THM 16 October 2014

A Neuroscience Vision: Right Partner, Right Time, Right Place